Live feed
Filing
SC 13D
SC 13D0001140361-16-058967·BAUPOST GROUP LLC/MA
Schedule 13D ownership disclosure
Orexigen Therapeutics, Inc.
Security class unavailable · CUSIP: 686164104
Event date: 2016-03-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 18.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-16-058967
- Form type
- SC 13D
- Filer
- BAUPOST GROUP LLC/MA
- CIK
- CIK 1061768
- Filed
- Mar 24, 2016
- Reporting period
- Mar 15, 2016
- Description
- Schedule 13D beneficial ownership